Sachs Neuroscience Innovation Forum Presentation

By Promis Neuro AdminJanuary 27, 2020Presentations

Webcast: Watch Dr. Elliot Goldstein discuss the ProMIS pipeline and explain how 2020 will be marked by momentum and hope for Alzheimer’s Disease from the Sachs Neuroscience Innovation Forum.

View or download the slides (PDF) via this link.

Next Post

ProMIS Neurosciences Appoints Dr. José Luis Molinuevo to its Scientific Advisory Board

About

ProMIS™ Neurosciences, Inc., headquartered in Toronto Ontario, and with offices in Cambridge Massachusetts, is publicly traded on the Toronto Stock Exchange (ticker symbol: PMN.TO) and OTCQB (ticker symbol: ARFXF).ProMIS is a development stage biotechnology company focused on discovering and developing antibody therapeutics selectively targeting toxic oligomers implicated in the development and progression of neurodegenerative diseases, in particular Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and Parkinson’s disease (PD).

Sachs Neuroscience Innovation Forum Presentation

Company News

Podcasts

Categories

Stock Ticker

Subscribe

ProMIS Neurosciences Appoints Dr. José Luis Molinuevo to its Scientific Advisory Board

About

Subscribe

Privacy Policy

Company News

Contact

Stock Ticker